(Q26745686)
Statements
Trial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapy (English)
0 references
2
0 references
e1012976
0 references
4
0 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference